Phenylpropanolamine (PPH) Lawyer: Decongestant Causes Stroke
by Anna Henningsgaard
Phenylpropanolamine, or PPH, used to be an active ingredient in many over the counter nasal decongestants and weight control drug products. The FDA pulled phenylpropanolamine off the market in May of 2000 when a Yale University School of Medicine study found that patients using PPH were at a higher risk of hemorrhagic stroke, or bleeding of the brain. By then it had been in popular use for many years, but because strokes are such serious and unpredictable afflictions and safer alternative drugs readily available, the FDA alerted customers to the danger and issued a recall on phenylpropanolamine.
The Yale University study found that women were at a higher risk of hemorrhaging and stroke than men, but that men were still at increased risk. The products using PPH were varied, but they all should have listed phenylpropanolamine as an active ingredient on the label and it is almost entirely unavailable in the US market. Recently forwarded email chains have warned of dozens of products that contain PPH, but this list is outdated and the products on this list have already removed phenylpropanolamine as a drug ingredient.
Some people maintain that the FDA was being overly cautious in removing phenylpropanolamine from the market, citing its years of successful use. PPH was only found to increase the risk of stroke during the first three days of use and mostly in female study participants. It is still an active ingredient in many drugs produced and sold outside of the United States, though it is generally unavailable in the US.
If you or someone you love has suffered a stroke while using phenylpropanolamine (PPH) or experienced any other negative side effects, contact a lawyer to discuss the PPH recall and your specific situation.